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BACKGROUND AND OBJECTIVES: Body mass index (BMI) is the most widely used measure to define obesity
and predict its complications, such as diabetes and hypertension, but its accuracy and usefulness in Saudi subjects is unknown. This study aimed to assess the validity of standard BMI cut-point values in the Saudi population.
SUBJECTS AND METHODS: 197 681 adults participated in a cross-sectional study to detect diabetes and hypertension in the Saudi Eastern province in 2004/2005, with blood pressure, fasting blood sugar, height and weight
measurements taken. Sensitivities, specificities, areas under the curves, predictive values, likelihood ratios, false
positive, false negatives and total misclassification ratios were calculated for various BMI values determined from
receiver operating characteristic (ROC) curves. The significance of the association between risk factors and BMI
was assessed using regression analysis.
RESULTS: For the definition of overweight, ROC curve analysis suggested optimal BMI cut-offs of 28.50 to 29.50
in men and 30.50 to 31.50 in women, but the levels of sensitivity and specificity were too low to be of clinical
value and the overall misclassification was unacceptably high across all the selected BMI values (>0.80). The
relationship between BMI and the presence of diabetes and/or hypertension was not improved when a BMI of
25 was used. Using regression analyses, the odds ratios for hypertension and/or diabetes increased significantly
from BMI values as low as 21-23 with no improvement in the diagnostic performance of BMI at these cutoffs.
CONCLUSION: In Saudi population, there is an increased risk of diabetes and hypertension relative to BMI,
starting at a BMI as low as 21 but overall there is no cutoff BMI level with high predictive value for the development of these chronic diseases, including the WHO definition of obesity at BMI of 30.

B

ody mass index (BMI) is widely used as a method to classify underweight, overweight and obesity. Around three quarters of Saudi dietitians
use this tool as outcome measure to assess the success
in weight loss.1 BMI is defined as the weight in kilograms divided by the square of the height in meters (kg/
m2). In 1997, the World Health Organization (WHO)
proposed cut-off points for classifying overweight and
obesity.2,3 Overweight is classified as BMI ≥25.0 and
obesity is classified as BMI ≥30.0. These cutoffs have
been identified on the basis of the association between
BMI and chronic diseases and mortality.2,4 Since these
criteria were derived from European populations their
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appropriateness for Non-European populations including the Saudi population, is unclear, and the recent
WHO monograph on obesity acknowledged the ‘need
for different standards that are “culturally specific”.2
It has been demonstrated that Asians have a higher
percentage of body fat than Caucasians at the same
BMI cut-off levels and the health risks associated
with obesity occur at a lower BMI cut-off level than
Caucasians.5-12 There have been a few attempts to investigate the applicability of the WHO BMI cut-offs in
Asian and Pacific populations.12-18 In 2000, the Regional
Office for the Western Pacific Region of WHO with
the International Association for the Study of Obesity
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(IASO) and the International Obesity Task Force
(IOTF) defined overweight in Asians as a BMI >23.0
and obesity as a BMI >25.0.13 In 2004, WHO did not
propose a clear BMI cut-off for all Asians, but they indicated that the cut-off points for observed risk varies
between BMI of 22.0 to 25.0 in different Asian populations and these values varies between BMI 26.0 to 31.0
for the high risk cut-off.
Even though BMI has been used extensively in research and clinical practice, there are only a few studies examining its diagnostic accuracy and no study has
examined this in a large, non-Caucasian adult population. Therefore, the present study aimed to assess the
ability of BMI to diagnose obesity relative to metabolic
risk factors and to determine the optimal BMI cut-off
points that could be used to classify obesity in the Saudi
population.

SUBJECTS AND METHODS

This study used data from a large survey conducted
in the Eastern Province of Saudi Arabia in 2004 and
2005. The aim of the survey was the early detection of
diabetes and hypertension and a detailed description
of the study design and data collection procedures has
been published elsewhere.19 Briefly, all Saudi residents
in the Eastern Province aged 30 years and older were
invited to participate in the survey. Pregnant women
and non-Saudi people were excluded from the survey.
For recruitment, a media campaign was organized in
each sector using written material and audiovisual media. In addition, posters were put up on billboards along
the streets and public places in the Eastern Province.
The estimated target population of Saudi residents in
the Eastern province aged ≥30 years was 650 000 individuals.20 A total of 197 681 Saudis responded to
the campaign’s invitation (30.4%) and 195 851 of them
had assessments of height and weight, and presence of
diabetes and/or hypertension and were included in the
analysis of the present project. The survey through this
convenience sample was conducted through more than
300 examination posts run by trained nurses and technicians distributed in the Eastern Province of Saudi
Arabia, including all Primary Health Care Centers
(PHCCs), governmental hospitals, and several private
health places, and other venues, in addition to mobile
teams who visited the target population in places of
work that had more than 30 employees.
Weight was measured to the nearest 0.5 kg using standardized beam weight scales (Detecto scale,
Cardinal Scale Mfg Co., USA) and recorded to the lowest unit without footwear and with only light clothes

438

on. Height was measured to the nearest centimeter
with the subjects barefoot and standing with the feet
together, ensuring the nape, back, calves and with the
ankles pressed against the measuring tape, which is part
of weighing scale. BMI was calculated as weight in kilograms divided by height in meters squared (kg/m2),
and standard WHO cut-off values of a BMI ≥25.0 as
overweight and a BMI ≥30.0 as obesity were used to
define the prevalence. Blood pressure was measured two
times while the subject was at rest in a sitting position.
The average of the two measurements was accepted if
the difference between the values was less than 5 mm
Hg. Measurement was taken using standardized mercury sphygmomanometers (Diplomat Presameter 660360 manufactured by Riester GMBH, Germany) with
an appropriate cuff inflated to a pressure approximately
30 mm Hg greater than systolic and with the subject's
arm at the level of the heart. The screening test for hypertension was considered positive if the systolic and
diastolic blood pressure was ≥140 and/or ≥90 mm Hg,
respectively.21 The diagnosis of hypertension was made
if positive screening was confirmed on a subsequent day,
or if there was a history of previous diagnosis, irrespective of the blood pressure reading. Participants who did
not come for the confirmatory test were diagnosed as
having hypertension if screening test of systolic and diastolic blood pressure was ≥180 and /or ≥110 mmHg,
respectively. These relatively high values were chosen
to avoid over diagnosing hypertension in participants
who might be in rush or anxious from the results of the
evaluation.
Whole blood glucose concentration was measured
for all participants using uniform portable glucometer
machines with a Medisafe Reader (Terumo Co., Tokyo,
Japan), based on reflectance photometry, where the glucose was catalytically oxidized by the glucose oxidase
and peroxides enzymes with a color change reaction. A
screening test was considered to be positive for hyperglycemia if Capillary Fasting Blood Glucose (CFBG)
was ≥100 mg/dL (≥5.6 mmol/L) after at least 8 hours
of fasting or the Capillary Random Blood Glucose
(CRBG) was ≥140 mg/dL (≥7.8 mmol/L) taken without consideration of the time of the last meal.22 A CFBG
of 100-125 mg/dl (5.6-6.9 mmol/l) and a CRBG of
140-199 mg/dl (7.8-11 mmol/l) were considered to
be consistent with impaired fasting glucose (IFG) and
impaired glucose tolerance (IGT), respectively. Initial
screening test was considered to be consistent with the
diagnosis of diabetes if the CFBG was ≥126 mg/dl
(≥7.0 mmol/l) or the CRBG was ≥200 mg/dl (≥11.0
mmol/l). Diabetes mellitus was diagnosed either by a

Ann Saudi Med 29(6)

November-December 2009

www.kfshrc.edu.sa/annals

[Downloaded free from http://www.saudiannals.net on Thursday, November 05, 2009]

original article

BMI and risk of diabetes & hypertension

positive history of diabetes or through the screening
test. All subjects who had been screened positive for
hyperglycemia without a history of diabetes were asked
to come in fasting for ≥8 hours, on the following day,
at the central laboratory, for confirmation of the results
by venous blood testing through the measurement of
fasting plasma glucose (FPG). Confirmatory FPG was
considered to be diagnostic for diabetes if it was ≥126
mg/dL (≥7.0 mmol/L). Participants who did not come
for the confirmatory test were diagnosed as having diabetes if screening test of CFBG was ≥200 mg/dl (11.0
mmol/l) or CRBG was ≥270 mg/dl (15.0 mmol/l).
Data were analyzed with SPSS software (version
17.0; SPSS Inc., Chicago, IL). All results are presented
as mean (SD) or percentage, where applicable. Data
analysis was performed in men and women separately.
BMI was stratified in unit of 0.5 for both men and
women. A BMI <19.9 was considered as the reference.
Logistic regression analysis was used to examine the independent relationship between the stratified BMI and
the odds ratio of having diabetes, hypertension, both
diabetes and hypertension and either diabetes or hypertension. P value<.001 was considered to be significant.
The optimal sensitivity and specificity using different
BMI cut-off values to predict the presence of diabetes
and/or hypertension were examined by receiver operating characteristic curve (ROC) analysis. A greater area
under the curve (AUC) indicates better predictive capability. An AUC=0.5 indicates that the test performs no
better than chance, and an AUC=1.0 indicates perfect
discrimination. An ideal test is one that reaches the upper left corner of the graph (100% true positives and
no false positives). To determine the optimal BMI cutoff points, we computed and searched for the shortest
distance between any point on the curve and the top
left corner on the y-axis. Distance was estimated at each
one-half unit of BMI according to the equation:23,24
Distance in ROC curve =

(1-sensitivity)2 + (1-specificity)2

Additional criteria were also used to select cut-offs,
including the greater sum of sensitivity and specificity,
the smallest misclassification rate, and the significant
associations between BMI and risk factors based on the
logistic regression. Diagnostic performance of BMI in
predicting diabetes and hypertension was assessed by
calculating AUC, sensitivity, specificity, predictive values (Positive Predictive Values and Negative Predictive
Values), likelihood ratios (LR+ and LR–), false positive
(FP), false negative (FN) and the total misclassification
rate.
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RESULTS

A total of 195 851 participants (99 946 men and 95 905
women) were included in the analysis. Table 1 shows
study population characteristics. The overall mean
(SD) BMI of participants was 29.69 (6.00). The mean
weight and height for men were 80.45 (15.94) kg and
1.67 (0.07) m and for women were 73.29 (16.1) kg
and 1.54 (0.07) m, respectively. The overall prevalence
of obesity (BMI≥30), overweight (BMI 25-29.9),
diabetes and hypertension were 43.8, 35.1, 17.2 and
15.6%, respectively. Results of the initial screening test
for participants with no previous diagnosis of diabetes or hypertension showed that 10.9% of participants
had IFG, IGT or diabetes and 9% had hypertension.
Analysis also showed that 59.3% of participants with
diabetes and 46% of participants with hypertension
had another confirmatory test. This means 4.4% and
4.9% of the total sample did not have the confirmatory test for the diagnosis of diabetes and hypertension.
However, >70% of participants who did not come for
the confirmatory test for diabetes had IFG or IGT. For
hypertension, 53.0 % of participants had diastolic blood
pressure ranged from 140 to 150 mmHg and 77.3% of
participants had diastolic blood pressure ranged from
90 to 100 mmHg.
Table 2 displays details of the diagnostic performance of BMI in detecting diabetes and/or hypertension using optimal BMI cut-off values based on the
shortest distance in ROC curve. Values ranged from
28.50 to 29.50 in men and from 30.50 to 31.50 in
women. The AUC ranged from 0.566 to 0.625 in men
and from 0.618 to 0.645 in women (Figure 1). These
values were statistically significantly higher than that
would be expected by chance alone (P<.001).
The corresponding sensitivities and specificities in
men ranged from 0.55 to 0.59 and 0.54 to 0.62, respecTable 1. Population characteristics (n=195 851).
Men

Women

Both genders

Weight (kg)

80.45 (15.94)

73.29 (16.1)

76.95 (16.43)

Height (m)

1.67 (0.07)

1.54 (0.07)

1.61 (0.10)

BMI (kg/m2)

28.67 (5.26)

30.75 (6.51)

29.69 (6.00)

Obese (%)

36.1

51.8

43.8

Overweight (%)

40.3

29.7

35.1

Diabetes (%)

15.9

18.6

17.2

Hypertension (%)

13.1

18.1

15.6
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Table 2. Diagnostic performance of BMI in detecting diabetes and/or hypertension using optimal BMI cut-off values based on the
shortest distance in ROC curves in Saudi adults, Eastern province, 2004, (n=195 851).
Risk factors

Gender

n

AUC
(95% CI)

Men

99946

0.566
(0.561-0.571)

28.50

0.55

0.54

0.19 0.87 1.21 0.82 0.46 0.45

0.91

Women 95905

0.618
(0.614-0.622)

31.50

0.58

0.61

0.25 0.86 1.48 0.69 0.39 0.42

0.81

0.6 25
(0.62-0.63)

29.00

0.59

0.58

0.18 0.91 1.42 0.70 0.42 0.41

0.83

0.645
(0.641-0.650)

31.50

0.60

0.62

0.25 0.87 1.55 0.66 0.39 0.41

0.80

99946

0.594
(0.590-0.598)

28.50

0.58

0.56

0.13 0.92 1.30 0.76 0.44 0.42

0.86

Women 95905

0.640
(0.636-0.643)

30.50

0.63

0.58

0.17 0.92 1.47 0.65 0.43 0.37

0.80

99946

0.618
(0.611-0.625)

29.50

0.55

0.62

0.08 0.96 1.44 0.73 0.38 0.45

0.83

Women 95905

0.643
(0.637-0.649)

31.50

0.61

0.59

0.12 0.94 1.55 0.66 0.41 0.39

0.80

Diabetes

Men

99946

Hypertension
Women 95905

Diabetes or
Hypertension

Diabetes and
Hypertension

Men

Men

Cut-offs
Sensitivity Specificity PPV
kg/m2

NPV LR + LR –

FP
rate

FN Misclassification
rate
rate

AUC: area under the curve; PPV: positive predictive value; NPV: negative predictive value; LR+: positive likelihood ratio; LR-: negative likelihood ratio; FP rate: false positive rate;
FN rate: false negative rate

tively, and in women they ranged from 0.58 to 0.63 and
0.58 to 0.62, respectively. LRs were close to 1.0 in both
men and women. The positive likelihood ratio (LR+)
ranged from 1.21 to 1.55 and the negative likelihood
ratio (LR–) ranged from 0.66 to 0.82. The PPV were
small, ranging from 0.08 to 0.25; NPV were high, ranging from 0.87 to 0.96. FP and FN rates were close to
each other and ranged from 0.38 to 0.46 and from 0.37
to 0.45, respectively. The overall misclassification was
unacceptably high across all the selected BMI values
(>.80). These cut-offs were selected based on the shortest distance in the ROC curves. However, when other
criteria applied, including the greater sum of sensitivity
and specificity, and the smallest misclassification rate,
the results were very similar (data not shown).
Table 3 shows the odds ratios of the association between diabetes and hypertension and BMI in men and
women. A significant positive association was observed
with BMI values starting at 21 to 23 and increasing
progressively with higher BMI values for both genders.
Table 4 displays the predictive value of BMI in detecting
diabetes and/or hypertension using BMI cut-off values
based on the lowest significant association between
BMI and the risk factors from the logistic regression
analysis. The diagnostic performance of BMI was also
assessed using a BMI of 25 (the value recommended by
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WHO to identify overweight), but the results showed
poor performance (data not shown).

DISCUSSION

This is the first population-based study to assess the
ability of BMI to diagnose obesity and to determine the
optimal BMI cut-off points for the Saudi population
based on the prevalence of diabetes and hypertension.
BMI has been shown to be associated with cardiovascular diseases such as diabetes and hypertension in
Caucasians.25-27 These relationships, which have been
used in many studies to assess the accuracy of BMI
in diagnosing obesity, have also been demonstrated in
Middle Eastern people, including Saudis.28-30 The use of
a reliable tool with optimal cut-off points for obesity diagnosis is very important to establish consequent public
health policies, treatment protocols and to determine
the correct prevalence of obesity for each population.
ROC curve analysis, using the endpoints of presence
of diabetes or hypertension, showed that the optimal
BMI cut-off points for overweight ranged from 28.50
to 29.50 for men and from 30.50 to 31.50 for women
depending on the risk factor being studied. These values
are higher than the suggested values by WHO, particularly in women. One possible reason for the high value
for women is the short stature in this group with a mean
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Figure 1. ROC curve showing the performance of BMI in predicting diabetes and hypertension (1a: diabetes in women, AUC=0.618
(95% CI 0.614 to 0.622); 1b: diabetes in men, AUC=0.566 (95% CI 0.561 to 0.571); 1c: hypertension in women, AUC=0.645 (95% CI 0.641 to
0.650); 1d: hypertension in men, AUC=0.625 (95% CI 0.620 to 0.630).

height of 1.54 m. Lara-Esqueda et al31 conducted a large
cross-sectional study (n=119, 975) to assess the ability
of the BMI to predict obesity-associated morbidity in
Mexican participants with normal or short stature. The
results showed that the BMI value with the best diagnostic proficiency ranged from 27 to 29 in normal stature women and from 28 to 29 in short stature women.
The authors concluded that the proficiency of BMI as
a diagnostic test is poor in short stature participants.
However, lowering the BMI threshold did not improve
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the ability of BMI to predict diabetes and hypertension
in that study and neither did it in our study as well.
The overall performance of the ROC curve can be
quantified by estimating the AUC which ranged from
0.57 to 0.65 (Table 4). An area of 1.0 is perfect and an
area <0.5 is considered non-informative. Our results
indicated that the ROC analysis was close to a non-informative test (Figure 1). To avoid a misleading conclusion, several other diagnostic characteristics of BMI as
a tool for obesity diagnosis were calculated.
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Table 3. Risk of diabetes and/or hypertension associated with increasing BMI in Saudi adults, Eastern province, 2004, based on
regression analysis (n=195 851).

BMI

Diabetes odds ratio
(95% CI)

Hypertension odds ratio
(95% CI)

Diabetes and hypertension
odds ratio (95% CI)

Diabetes or hypertension
odds ratio (95% CI)

Men

Women

Men

Women

Men

Women

Men

Women

21

1.43*
(1.16-1.78)

1.28
(0.98-1.67)

1.15
(0.89-1.48)

1.05
(0.82-1.34)

1.47
(0.93-2.30)

1.64
(1.09-2.45)

1.30*
(1.08-1.55)

1.05
(0.86-1.29)

22

1.67*
(1.38-2.03)

1.63*
(1.29-2.05)

1.11
(0.88-1.41)

1.22
(0.98-1.50)

1.59
(1.06-2.40)

1.59
(1.10-2.32)

1.41*
(1.20-1.66)

1.37*
(1.15-1.63)

23

1.99*
(1.67-2.38)

2.00*
1.63-2.47)

1.53*
(1.25-1.87)

1.34*
(1.10-1.62)

2.21*
(1.53-3.17)

2.23*
(1.59-3.11)

1.76*
(1.53-2.04)

1.53*
(1.30-1.79)

24

2.22*
(1.88-2.63)

1.99*
(1.63-2.44)

1.69*
(1.40-2.05)

1.55*
(1.29-1.86)

2.47*
(1.74-3.49)

2.14*
(1.55-2.97)

1.98*
(1.72-2.27)

1.70*
(1.46-1.97)

25

2.43*
(2.07-2.86)

2.71*
(2.24-3.28)

2.00*
(1.66-2.38)

1.80*
(1.51-2.13)

3.02*
(2.16-4.21)

2.86*
(2.10-3.89)

2.20*
(1.93-2.51)

2.12*
(1.84-2.45)

26

2.80*
(2.39-3.28)

2.85*
(2.34-3.44)

2.08*
(1.74-2.49)

1.84*
(1.55-2.19)

3.26*
(2.35-4.53)

2.79*
(2.06-3.79)

2.47*
(2.17-2.81)

2.25*
(1.95-2.59)

27

2.76*
(2.36-3.23)

2.85*
(2.36-3.44)

2.45*
(2.06-2.92)

2.03*
(1.72-2.40)

3.69*
(2.67-5.12)

3.56*
(2.64-4.79)

2.59*
(2.28-2.95)

2.51*
(2.19-2.88)

28

3.01*
(2.57-3.51)

3.37*
(2.80-4.05)

2.72*
(2.29-3.24)

2.27*
(1.93-2.67)

4.54*
(3.29-6.26)

4.27*
(3.19-5.71)

2.78*
(2.45-3.16)

2.85*
(2.49-3.27)

29

3.25*
(2.78-3.80)

3.94*
(3.29-4.73)

2.90*
(2.43-3.45)

2.54*
(2.16-2.99)

4.31*
(3.11-5.95)

4.32*
(3.23-5.79)

3.11*
(2.74-3.54)

3.39*
(2.96-3.88)

30

3.35*
(2.87-3.92)

4.50*
(3.76-5.39)

3.07*
(2.58-3.65)

2.80*
(2.39-3.29)

4.77*
(3.46-6.59)

4.66*
(3.48-6.22)

3.20*
(2.82-3.64)

3.68*
(3.22-4.20)

31

3.46*
(2.96-4.05)

4.73*
(3.96-5.66)

3.60*
(3.02-4.28)

3.00*
(2.56-3.52)

5.89*
(4.28-8.12)

5.23*
(3.92-6.99)

3.40*
(3.00-3.87)

3.79*
(3.324.34)

*Odds of disease significant (P<.001) when compared with BMI < 20 as a reference group

ROC curve analysis showed that the corresponding sensitivities and specificities were poor (<0.63 and
<0.62, respectively). This indicates that the percentage
of people identified as having the risk factors and the
percentage of people who were identified as not being
at risk were less than 63% of total population. Both
LR+ and LR– were close to 1.0, indicating a minimal
increase in the likelihood of the presence of the risk factor if the test is positive and a minimal decrease in the
likelihood if the test is negative. PPVs were small and
ranged from 0.08-0.25. This indicates that the proportion of overweight and obese people who were classified
correctly as overweight or obese was <25%. On other
hand, the proportion of non-overweight or non-obese
people who were classified correctly were ranged from
86% to 96% as indicated by the NPVs. The FP and FN
rates were high and close to each other in both women
and men. The overall misclassification was very high
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and exceeded 80% of the total population across all the
selected BMI cut-off points.
The technical statistical term “diagnostic performance” has been used to characterize the relationship
between BMI and presence of diabetes or hypertension. This does not mean that BMI is used a diagnostic
clinical test for these conditions. However, clinicians
will generally be more concerned about false negatives,
when patients at risk may be overlooked for treatment.
By using BMI as a tool for assessing the metabolic risks
of being overweight or obese, these findings suggest that
37% to 45% of people with risk factors would be incorrectly identified as healthy, as indicated by the FN rate.
The percentage varies depending on the risk factors being studied. This finding is also supported by the high
values of specificities and NPVs and the values of LR-.
The use of the higher BMI cut-off values suggested by
the ROC analysis (Table 2) would misclassify large
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Table 4. Diagnostic performance of BMI in detecting diabetes and/or hypertension using optimal BMI cut-off values based on the
significant association using logistic regression in Saudi adults, Eastern province, 2004, (n=195 851).
Risk factors

Gender

n

AUC
(95% CI)

Men

99946

0.566
(0.561-0.571)

21

0.98

0.06

0.16 0.94 1.04 0.33 0.94 0.02

0.96

Women 95905

0.618
(0.614-0.622)

22

0.98

0.08

0.20 0.95 1.07 0.25 0.92 0.02

0.94

0.625
(0.62-0.63)

23

0.95

0.13

0.14 0.95 1.09 0.38 0.87 0.05

0.92

0.645
(0.641-0.650)

23

0.96

0.12

0.19 0.93 1.09 0.33 0.88 0.04

0.92

99946

0.594
(0.590-0.598)

21

0.98

0.06

0.11 0.96 1.04 0.33 0.94 0.02

0.96

Women 95905

0.640
(0.636-0.643)

22

0.97

0.09

0.13 0.95 1.07 0.33 0.91 0.03

0.94

0.618
(0.611-0.625)

23

0.96

0.12

0.06 0.98 1.09 0.33 0.88 0.04

0.92

23

0.97

0.11

0.09 0.98 1.09 0.33 0.89 0.03

0.92

Diabetes

Men

99946

Hypertension
Women 95905

Diabetes or
Hypertension

Diabetes and
Hypertension

Men

Men

99946

Women 95905

Cut-offs
FP
Sensitivity Specificity PPV NPV LR + LR kg/m2
rate

0.643
(0.637-0.649)

FN
rate

Misclassification
rate

AUC: area under the curve; PPV: positive predictive value; NPV: negative predictive value; LR+: positive likelihood ratio; LR-: negative likelihood ratio; FP rate: false positive rate;
FN rate: false negative rate.

percentages of people with risk factors as being healthy
who might then miss the opportunity for treatment.
To reduce the large chance of such misclassification,
we attempted to identify cut-offs based on the observed
significant association between BMI and risk factors.
Regression analysis showed that the risk of diabetes
and/or hypertension was significantly increased at BMI
values as low as 21-23 and increased progressively as
BMI increased. Applying this criterion to identify the
cut-off values resulted in improvements in sensitivity, NPV, LR‒, FN and worsening in specificity, PPV,
LR+, FP and the overall misclassification rate. Using
these lower BMI cut-offs resulted in a very small FN
rate ranging from 0.02 to 0.05. Therefore, most people
with risk factors were correctly identified as at risk. This
finding may suggest obesity management should be
considered even at a quite low BMI values in the Saudi
population.
This is not the first study to suggest the presence of
a significantly increased risk of co-morbidities at BMI
values less than 25. In a Chinese population in Hong
Kong, diabetes and hypertension were also reported to
increase from a BMI value of 22 onwards.38 However,
the use of such low cut-offs would lead to large misclassification of healthy people as being at risk, as indicted
by the high values of sensitivities and FP rates. This fact
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that could cause unnecessary and costly diagnostic testing. Overall the total misclassification rate was unacceptably high, even with the use of different BMI cut off
points and different selection criteria, and even with the
use of the recommended value by WHO (BMI=25).
These findings illustrate the significant limitations in
using BMI alone for obesity diagnosis in the Saudi
Arabian population.
To our knowledge, only one study has assessed the
optimal BMI cut-off points on a sample of the Arab
population of the Middle East, which was conducted
in 1420 Omani adult subjects.32,33 The authors analyzed that study using two different definitions of cardiovascular disease (CVD) risk. When CVD risk was
identified as the presence of at least two out of three
risk factors (hyperglycemia, hypertension and dyslipidemia), the optimal BMI cut-off points for men and
women were 23.2 and 26.8, respectively.32 Using the
Framingham risk score, the optimal cut-off points for
men and women were 22.6 and 22.9, respectively.33 The
use of the first definition resulted in moderate sensitivity (71.0) and poor specificity (53.7) with AUC of
0.65 in men and poor sensitivity (46.8) and moderate
specificity (76.5) with AUC of 0.66 in women. Using
the Framingham risk score resulted in good sensitivity
(80.3), very poor specificity (37.3) and AUC of 0.60 in
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men, and good sensitivity (84.2), poor specificity (45.1)
and AUC of 0.64 in women. Both methods indicated
that waist-to-hip ratio (WHR) and waist circumference (WC) were better surrogates to detect CVD risk
compared to BMI. One major limitation of that study
was the small sample size, which may limit the generalizability of the findings to other Middle Eastern populations. Unfortunately, other diagnostic characteristics
of BMI as a tool for obesity diagnosis were not calculated.
Most of the other previous studies that have been
conducted in non-Caucasian populations did not assess
the misclassification rate.15,24,32-38 However, one study
conducted in Asian Indians also indicated a high overall
misclassification rate, particularly in women.39 Those
authors concluded that the BMI did not accurately predict overweight in that population.
Several reasons may explain the weakness of BMI as
a tool to classify obesity in the Saudi Arabian population. First, BMI does not reflect fatness uniformly in all
populations and different ethnic groups.9,39-41 The previous Omani study indicated that WHR and WC better predict CVD risk than BMI.32,33 This may suggest
the importance of including a measure of abdominal
obesity in classifying obesity in Middle East populations such as those in Oman and Saudi Arabia. Second,
the short stature of Saudi women could be limiting the
usefulness of BMI in this population.
Strengths and limitations of this study should be
recognized. The very large number of participants provided sufficient cases at each single unit of BMI to assess the significance of association between each BMI
unit and the presence of diabetes or hypertension. In
contrast, the cross-sectional nature of the survey and
the absence of measurements of other relevant obesityrelated co-morbidities, such as hypercholesterolemia
and hypertriglyceridemia, could be considered as limi-
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tations in this study. The sample was a convenience
non-random sample. However, it is fairly representative of the target population. When we compared the
sub-classification of respondents with the latest census
done in the eastern province regarding to age and sex,
the characteristics of the study sample were similar.20
The relatively low response rate of participants coming
for the confirmatory diagnostic test and the reliance
on a single screening test using capillary blood glucose
may have had an effect on the low performance of BMI
in predicting diabetes and hypertension in this study.
Also the relatively high values chosen for the definition of diabetes and hypertension for participants who
did not come for the confirmatory test may have had
a similar negative effect on the performance of BMI.
However, >70% of participants who did not come for
the confirmatory test for diabetes had IFG or IGT
based on CFBS and CRBS. The situation was also
similar for hypertension. Whether similar conclusions
would be reached had this study been done on a random sample with avoidance of the above-mentioned
limitations or not remains to be seen in future studies. Similarly, it is not clear if such conclusion would
be obtained in a national sample covering other regions
of Saudi Arabia.
In conclusion, the diagnostic usefulness of BMI
alone in defining obesity is limited in this large population of Saudi adults in the Eastern Province, for both
men and women. Future studies incorporating other
measures such as WC, WHR, body fat composition,
or a combination of tools, need to be conducted to determine the best method to classify obesity accurately
in the Saudi population. It seems likely however that
limiting management of obesity to those individuals
with a BMI>30 may mean that many Saudis at risk of
serious co-morbidities could be missing necessary interventions.
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